SCHEMBL30106048

SCHEMBL30106048

Cc1ccc(S(N)(=O)=O)c(CCC(C)Oc2nc3c(ccn3COCC[Si](C)(C)C)cc2Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30106008 0.89 DGAT1 (0.32) —
SCHEMBL23908133 0.82 — —
SCHEMBL20767594 0.80 ALDH1A1 (0.37) —
SCHEMBL20767654 0.78 GBA1 (0.35) —
SCHEMBL20767653 0.78 GBA1 (0.35) —
SCHEMBL30106041 0.74 — —
SCHEMBL21751511 0.74 MTNR1A (0.37) —
SCHEMBL21751510 0.74 MTNR1A (0.37) —
SCHEMBL29748502 0.73 — —
SCHEMBL30154394 0.73 PCSK9 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110298-A1 HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2 INHIBITOR Guangzhou Lupeng Pharmaceutical Company Ltd. (CN) 2023-01-04 — — EP disclosed
Send feedback